Song Feng

Building 5, No. 371, Lishizhen Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection.

Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection.

Journal: Journal of medicinal chemistry

Published: August 16, 2022

Discovery of a first-in-class orally available HBV cccDNA inhibitor.

Discovery of a first-in-class orally available HBV cccDNA inhibitor.

Journal: Journal of hepatology

Published: August 25, 2021

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

Journal: Journal of medicinal chemistry

Published: June 14, 2019

Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors.

Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors.

Journal: MedChemComm

Published: March 26, 2019

Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors.

Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors.

Journal: Journal of medicinal chemistry

Published: October 20, 2018

Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection.

Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection.

Journal: ACS infectious diseases

Published: January 26, 2018

Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.

Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.

Journal: European journal of medicinal chemistry

Published: May 27, 2017

Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors.

Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors.

Journal: ACS medicinal chemistry letters

Published: June 10, 2015

Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitors.

Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitors.

Journal: ACS medicinal chemistry letters

Published: January 08, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026